BERKELEY LIGHTS INC (BLI) Fundamental Analysis & Valuation
NASDAQ:BLI • US0843101017
Current stock price
1.2 USD
-0.07 (-5.88%)
At close:
1.21 USD
+0.01 (+0.83%)
After Hours:
This BLI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. BLI Profitability Analysis
1.1 Basic Checks
- BLI had negative earnings in the past year.
- In the past year BLI has reported a negative cash flow from operations.
1.2 Ratios
- BLI has negative profitability rations, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With an excellent Gross Margin value of 68.43%, BLI belongs to the best of the industry, outperforming 89.06% of the companies in the same industry.
- BLI's Gross Margin has declined in the last couple of years.
- BLI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.43% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.73%
GM growth 5YN/A
2. BLI Health Analysis
2.1 Basic Checks
- BLI does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, BLI has more shares outstanding
- Compared to 1 year ago, BLI has a worse debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of -2.23, we must say that BLI is in the distress zone and has some risk of bankruptcy.
- BLI has a Altman-Z score of -2.23. This is amonst the worse of the industry: BLI underperforms 81.25% of its industry peers.
- BLI has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
- BLI has a Debt to Equity ratio (0.10) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -2.23 |
ROIC/WACCN/A
WACC8.97%
2.3 Liquidity
- A Current Ratio of 3.89 indicates that BLI has no problem at all paying its short term obligations.
- BLI's Current ratio of 3.89 is in line compared to the rest of the industry. BLI outperforms 51.56% of its industry peers.
- A Quick Ratio of 3.48 indicates that BLI has no problem at all paying its short term obligations.
- The Quick ratio of BLI (3.48) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.89 | ||
| Quick Ratio | 3.48 |
3. BLI Growth Analysis
3.1 Past
- The earnings per share for BLI have decreased strongly by -33.64% in the last year.
- Looking at the last year, BLI shows a decrease in Revenue. The Revenue has decreased by -7.96% in the last year.
- BLI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.51% yearly.
EPS 1Y (TTM)-33.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-57.69%
Revenue 1Y (TTM)-7.96%
Revenue growth 3Y11.51%
Revenue growth 5YN/A
Sales Q2Q%-23.05%
3.2 Future
- BLI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.00% yearly.
- Based on estimates for the next years, BLI will show a quite strong growth in Revenue. The Revenue will grow by 17.80% on average per year.
EPS Next Y24.43%
EPS Next 2Y15.53%
EPS Next 3Y19%
EPS Next 5YN/A
Revenue Next Year11.33%
Revenue Next 2Y15.66%
Revenue Next 3Y17.8%
Revenue Next 5YN/A
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. BLI Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for BLI. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BLI. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- BLI's earnings are expected to grow with 19.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.53%
EPS Next 3Y19%
5. BLI Dividend Analysis
5.1 Amount
- BLI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BLI Fundamentals: All Metrics, Ratios and Statistics
1.2
-0.07 (-5.88%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-23 2023-02-23/amc
Earnings (Next)05-08 2023-05-08/amc
Inst Owners5.31%
Inst Owner Change0%
Ins Owners2.36%
Ins Owner Change0%
Market Cap47.72M
Revenue(TTM)78.59M
Net Income(TTM)-98.04M
Analysts69.09
Price Target7.65 (537.5%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-28.89%
Min EPS beat(2)-51.47%
Max EPS beat(2)-6.32%
EPS beat(4)0
Avg EPS beat(4)-19.23%
Min EPS beat(4)-51.47%
Max EPS beat(4)-1.55%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-15.01%
Min Revenue beat(2)-28.18%
Max Revenue beat(2)-1.84%
Revenue beat(4)0
Avg Revenue beat(4)-10.57%
Min Revenue beat(4)-28.18%
Max Revenue beat(4)-1.06%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-26.83%
PT rev (3m)-26.83%
EPS NQ rev (1m)-4.32%
EPS NQ rev (3m)5.44%
EPS NY rev (1m)-15.47%
EPS NY rev (3m)-15.47%
Revenue NQ rev (1m)-2.29%
Revenue NQ rev (3m)-19.43%
Revenue NY rev (1m)-4.87%
Revenue NY rev (3m)-4.87%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.61 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.34 | ||
| P/tB | 0.34 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.43
EYN/A
EPS(NY)-1.08
Fwd EYN/A
FCF(TTM)-1.4
FCFYN/A
OCF(TTM)-1.2
OCFYN/A
SpS1.98
BVpS3.57
TBVpS3.57
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.43% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.73%
GM growth 5YN/A
F-Score4
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 89.69% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.89 | ||
| Quick Ratio | 3.48 | ||
| Altman-Z | -2.23 |
F-Score4
WACC8.97%
ROIC/WACCN/A
Cap/Depr(3y)145.63%
Cap/Depr(5y)157.51%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-57.69%
EPS Next Y24.43%
EPS Next 2Y15.53%
EPS Next 3Y19%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.96%
Revenue growth 3Y11.51%
Revenue growth 5YN/A
Sales Q2Q%-23.05%
Revenue Next Year11.33%
Revenue Next 2Y15.66%
Revenue Next 3Y17.8%
Revenue Next 5YN/A
EBIT growth 1Y-33.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year29.77%
EBIT Next 3Y22.9%
EBIT Next 5YN/A
FCF growth 1Y19.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y10.52%
OCF growth 3YN/A
OCF growth 5YN/A
BERKELEY LIGHTS INC / BLI Fundamental Analysis FAQ
What is the fundamental rating for BLI stock?
ChartMill assigns a fundamental rating of 3 / 10 to BLI.
What is the valuation status for BLI stock?
ChartMill assigns a valuation rating of 3 / 10 to BERKELEY LIGHTS INC (BLI). This can be considered as Overvalued.
How profitable is BERKELEY LIGHTS INC (BLI) stock?
BERKELEY LIGHTS INC (BLI) has a profitability rating of 1 / 10.
Can you provide the expected EPS growth for BLI stock?
The Earnings per Share (EPS) of BERKELEY LIGHTS INC (BLI) is expected to grow by 24.43% in the next year.